- Home
- GNLN vs PRFX Comparison
GNLN vs PRFX Comparison
Compare GNLN & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLN | PRFX |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Durable Goods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.6M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GNLN | PRFX |
|---|---|---|
| Price | $0.30 | $2.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 284.6K | 26.1K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.57 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,275,000.00 | N/A |
| Revenue This Year | $1,541.21 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.01 | $0.58 |
| 52 Week High | $7.73 | $3.71 |
Technical Indicators
Market Signals| Indicator | GNLN | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 26.61 | 40.88 |
| Support Level | N/A | $1.28 |
| Resistance Level | $0.89 | $3.65 |
| Average True Range (ATR) | 0.12 | 0.24 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 6.58 | 24.74 |
Price Performance
Historical ComparisonAbout GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.
About PRFX PainReform Ltd.
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasise reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the Company's lead product, is based on the local anaesthetic ropivacaine and targets the postoperative pain relief market.